GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ABL Bio Inc (XKRX:298380) » Definitions » Other Stockholders Equity

ABL Bio (XKRX:298380) Other Stockholders Equity : ₩30,418 Mil (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is ABL Bio Other Stockholders Equity?

ABL Bio's Other Stockholders Equity for the quarter that ended in Mar. 2024 was ₩30,418 Mil.

ABL Bio's quarterly Other Stockholders Equity increased from Sep. 2023 (₩27,234 Mil) to Dec. 2023 (₩28,718 Mil) and increased from Dec. 2023 (₩28,718 Mil) to Mar. 2024 (₩30,418 Mil).

ABL Bio's annual Other Stockholders Equity declined from Dec. 2021 (₩26,194 Mil) to Dec. 2022 (₩23,580 Mil) but then increased from Dec. 2022 (₩23,580 Mil) to Dec. 2023 (₩28,718 Mil).


ABL Bio Other Stockholders Equity Historical Data

The historical data trend for ABL Bio's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ABL Bio Other Stockholders Equity Chart

ABL Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Stockholders Equity
Get a 7-Day Free Trial 18,248.32 24,135.52 26,194.07 23,580.42 28,718.01

ABL Bio Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24,938.17 26,077.43 27,234.18 28,718.01 30,417.84

ABL Bio Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


ABL Bio Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of ABL Bio's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


ABL Bio (XKRX:298380) Business Description

Traded in Other Exchanges
N/A
Address
2nd Floor, 16 Daewangpangyo-Ro 712, Beon-Gil, Bundang-Gu, Gyeonggi-do, Seongnam-si, KOR, 13488
ABL Bio Inc is a Korean biotech research company. The company is engaged in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline products include ABL001 an Bispecific Antibody, ABL201-205 an Antibody Drug Conjugate, T cell engager, Dual Immune Cell Targeting BsAb an Immuno-Oncology, ABL301 an BBB-Penetrating Bispecific Antibody.

ABL Bio (XKRX:298380) Headlines

No Headlines